Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active pharmaceutical ingredients (APIs) and critical GMP intermediates announced the ...

ClearVPN is a virtual private network service designed to encrypt internet traffic and mask online activity. At its core, a ...

The 10-year framework agreement between X-energy Reactor Company and SGL Carbon LLC covers the supply of graphite for the ...

The first two days of the J.P. Morgan Healthcare Conference are in the books, and attendees are now pushing through to finish ...

UNSW researchers found that some POE encapsulants can trigger severe corrosion in TOPCon solar modules, causing up to 55% power loss under damp-heat conditions. Their study highlights that module ...

European Commission approves Sobi’s Aspaveli for the treatment of C3G and primary IC-MPGN: Stockholm Monday, January 19, 2026, 10:00 Hrs [IST] Sobi, a global biopharma company u ...

Hugel, Inc., a leading global medical aesthetics company publicly traded in South Korea, has outlined its vision to transform from the leading Korean toxin company into a leader in global aesthetics.

Sobi® (STO: SOBI), today announced that the European Commission (EC) has approved Aspaveli® (pegcetacoplan) for the treatment of adult and adolescent patients aged 12 to 17 years with C3 ...

On paper, this looks like an administrative concession, but in operational reality, it is a competitiveness move designed to ...

Approximately 8,000 people in Europe are living with C3G or primary IC-MPGN Aspaveli (pegcetacoplan) is the first treatment of primary IC-MPGN and the first treatment for C3G and primary IC-MPGN ...

The hemophagocytic lymphohistiocytosis market is expected to increase due to the launch of emerging therapies, such as plonmarlimab (TJ Biopharma), ELA026 (Electra Therapeutics), MAS825 (Novartis) ...

Your digestive tract is home to trillions of bacteria that dictate your immunity and mental health; unfortunately, these ...